Artificial intelligence (AI) appears as if it could be one of the game-changing technologies of this generation. Many of the ...

Patients in the Veritac-2 study were randomized to receive a standard estrogen blocker called fulvestrant, or Arvinas' vepdegestrant. If the experimental estrogen degrader delays tumor growth longer ...

Drug maker Alumis (ALMS) is climbing 7% after investment bank Oppenheimer started coverage of the name with an Outperform ...

Instead, it is venturing into many different areas and in some cases single-handedly showing the world how to use AI in new, dynamic ways. (I elaborated on why I think NVIDIA will be the Stock of ...

Nebius shows massive growth potential with a 766% revenue increase in Q3 2024, driven by its AI infrastructure ... together gives me a $101.2 price target for NBIS stock. This price target however ...